 | Up a level |
Masjedi, A and Ahmadi, A and Ghani, S and Malakotikhah, F and Nabi Afjadi, M and Irandoust, M and Karoon Kiani, F and Heydarzadeh Asl, S and Atyabi, F and Hassannia, H and Hojjat-Farsangi, M and Namdar, A. and Ghalamfarsa, G and Jadidi-Niaragh, F (2020) Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy. Nanomedicine: Nanotechnology, Biology, and Medicine, 29. ISSN 15499634
Salimifard, S and Masjedi, A and Hojjat-Farsangi, M and Ghalamfarsa, G and Irandoust, M and Azizi, G and Mohammadi, H and Keramati, M.R and Jadidi-Niaragh, F (2020) Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathology Research and Practice, 216 (5). p. 152915. ISSN 03440338
Bastaki, S and Irandoust, M and Ahmadi, A and Hojjat-Farsangi, M and Ambrose, P and Hallaj, S and Edalati, M and Ghalamfarsa, G and Azizi, G and Yousefi, M and Chalajour, H and Jadidi-Niaragh, F (2020) PD-L1/PD-1 axis as a potent therapeutic target in breast cancer. Life Sciences, 247. p. 117437. ISSN 00243205
Masjedi, A and Ahmadi, A and Atyabi, F and Farhadi, S and Irandoust, M and Khazaei-Poul, Y and Ghasemi Chaleshtari, M and Edalati Fathabad, M and Baghaei, M and Haghnavaz, N and Baradaran, B and Hojjat-Farsangi, M and Ghalamfarsa, G and Sabz, G and Hasanzadeh, S and Jadidi-Niaragh, F (2020) Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. International Journal of Biological Macromolecules, 149. pp. 487-500. ISSN 01418130
